Extended Follow-up of the Multi-Center Multi-National Prospective Cohort Study That Derived the "Men Continue and HERDOO2" Clinical Decision Rule Which Identifies Low Risk Patients Who May Be Able to Discontinue Oral Anticoagulants (Oac) 5-7 Months After Treatment for Unprovoked Venous Thromboembolism (VTE). Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Rodger, Marc
  • Kovacs, Michael J
  • Kahn, Susan
  • Wells, Phil
  • Anderson, David
  • Gregoire, Le Gal
  • Solymoss, Susan
  • Chagnon, Isabelle
  • Crowther, Mark
  • Perrier, Arnaud
  • White, Richard H
  • Betancourt, Marisol
  • Carrier, Marc

publication date

  • November 20, 2009

published in